Wang, Yufeng
Drum, David L.
Sun, Ruochuan
Zhang, Yida
Chen, Feng
Sun, Fengfei
Dal, Emre
Yu, Ling
Jia, Jingyu
Arya, Shahrzad
Jia, Lin
Fan, Song http://orcid.org/0000-0002-6387-9361
Isakoff, Steven J. http://orcid.org/0000-0002-6677-1014
Kehlmann, Allison M.
Dotti, Gianpietro http://orcid.org/0000-0002-2639-8526
Liu, Fubao
Zheng, Hui
Ferrone, Cristina R.
Taghian, Alphonse G.
DeLeo, Albert B.
Ventin, Marco http://orcid.org/0000-0002-4201-7009
Cattaneo, Giulia
Li, Yongxiang http://orcid.org/0000-0002-4830-9467
Jounaidi, Youssef
Huang, Peigen http://orcid.org/0000-0002-3184-6493
Maccalli, Cristina
Zhang, Hanyu
Wang, Cheng http://orcid.org/0000-0002-0911-8254
Yang, Jibing
Boland, Genevieve M. http://orcid.org/0000-0002-7522-6173
Sadreyev, Ruslan I.
Wong, LaiPing
Ferrone, Soldano http://orcid.org/0000-0003-2900-8834
Wang, Xinhui http://orcid.org/0000-0003-3674-3685
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01DE028172, R01CA226981)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Defense (W81XWH2110433)
Article History
Received: 31 October 2022
Accepted: 29 August 2023
First Online: 15 September 2023
Competing interests
: G.D., S.F., X.W., and C.R.F. report two patents on the B7-H3 CAR T cells (US10519214B2: Methods and compositions for chimeric antigen receptor targeting cancer cells) and CSPG4 CAR T cells (US20210252067A1: Methods and compositions for chimeric antigen receptor targeting cancer cells). The remaining authors declare no other competing interests.